Exchange: NASDAQ·Updated 09:45 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 14

Estimated EPS

-$1.39

Reported EPS

-$1.46

Surprise

-5.32%

Estimated Rev

$6.53M

Reported Rev

$6.62M

Surprise

+1.41%

• Reported GAAP EPS of -$4.12 up 40.80% YoY • Reported revenue of $6.62M up 15.71% YoY • Lifeward expects its revenue momentum to continue in the second half of 2026, supported by a strong sales pipeline for the Company's portfolio of commercialized neurorehabilitation products and biomedical pipeline.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.79
--
--
N/A
Q2 '26
-$1.39
-$1.46
-5.32%
MISSED
Q1 '26
-$1.18
-$3.13
-165.25%
MISSED
Q4 '25
-$0.96
-$2.85
-196.87%
MISSED
Q3 '25
-$0.20
-$2.28
-1040.00%
MISSED

Advertisement|Remove ads.